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A B S T R A C T
Background: Congenital hyperinsulinism is a rare disease and patients not re-
sponding to medical treatment need near-total or partial pancreatectomy, dependent on whether they have diffuse or focal hyperinsulinism, respectively. While
laparoscopic technique for distal and for total pancreatectomy has been developed, minimally invasive resection of the pancreatic neck with pancreatico-jejunostomy
has not been reported in children before.
Case summary: A 2-year old boy suffered from congenital hyperinsulinism, which was refractory to high-dose medical treatment. The nuclear-medicine scan revealed
a focal lesion of the pancreatic neck, hence partial pancreatectomy was indicated. On laparoscopy, a slightly prominent tissue mass was apparent in the area of the
pancreatic neck. We proceeded with laparoscopic mobilisation of the pancreas from the underlying splenic vessels and resected the pancreatic neck and adjacent
parts of the body and the head. After macroscopic resection of the mass, the patient's intraoperative blood glucose levels increased to a point where insulin had to be
substituted. To drain the pancreatic tail, we formed an end-to-side anastomosis in the proximal Jejunum and brought the open end to the pancreatic tail and
performed a laparoscopic pancreatico-jejunostomy. The patient tolerated the procedure well and had no remaining signs or symptoms of hyperinsulinism.
Conclusion: This is the first report of a laparoscopic middle-segmental pancreatic resection with laparoscopic assisted Roux-en-Y pancreatico-jejunostomy in a child.
For benign pancreatic lesions proximal to the body and tail, the described minimally invasive technique should be considered.
1. Introduction
Congenital hyperinsulinism (HI) occurs in 1–1.4 neonates of 50′000
live births [1–3]. However, it is more common up to 1 in 2500 in
consanguineous populations. Patients who do not respond to medical
treatment require partial or near-total pancreatectomy for focal or
diffuse HI, respectively [4]. While open surgical technique is still the
most commonly chosen approach for subtotal pancreatectomy in cases
of diffuse HI, minimally invasive surgery (MIS) is an alternate approach
for focal lesions, especially when they are located in the pancreatic tail
[5]. Imaging studies combining data from computed tomography and
nuclear medical scans can be particularly helpful in preoperative
planning in focal disease [6,7]. Intraoperative frozen sections are in-
dispensable for confirming the diagnosis and determining the extent of
resection for both, diffuse and focal forms of HI. Herein, we present a
case of focal congenital HI, with challenging intraoperative decision
making and the first description of a paediatric minimally invasive re-
section of the pancreatic neck and body with laparoscopic pancreatico-
jejunostomy.
2. Case report
A 2-year old boy with congenital HI with paternal ABCC8 mutation
had intermittent hypoglycaemic episodes despite being on intensive
feeding regime (3-hourly bolus feeds and overnight continuous feeds
via gastrostomy), high-dose treatment with Octreotide at 39 μg/kg/day
and Sirolimus 0.8 mg twice daily (3.2mg/m2/day). The child had
maximum fasting tolerance of 3 h. A focal lesion of the pancreatic neck
was confirmed on a 18F-DOPA PET scan done 4 weeks prior to the
planned operation (Fig. 1). A peripherally inserted central catheter
(PICC) was placed 3 days preoperatively.
After induction of anaesthesia a single dose of Co-Amoxicillin was
administered, and an epidural catheter was placed. We placed a 10mm
Hasson port supra umbilically and working ports in both flanks. After
entering the lesser sac through the gastrocolic ligament, we placed a
Nathanson liver retractor to elevate the stomach, which provided access
to the pancreas. We identified a tissue mass in the neck area (Fig. 1).
Freeing up the cranial border of the pancreas using hook cautery fol-
lowed by separating the pancreas from the splenic vessels starting at the
lower border of the pancreatic body allowed complete transection of
the pancreatic body distal to the perceived nodular mass (Fig. 2). We
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then continued the separation of the pancreas from the splenic vessels
towards the neck until the mass with the adjacent normal appearing
pancreas could be removed via the umbilical port. The proximal
transection of the pancreas was carried out using a laparoscopic Har-
monic® (Ethicon®, Cincinnati, OH) scalpel to seal the parenchyma and
the pancreatic duct (Fig. 3), while laparoscopic hook cautery was used
for the previous distal transection [8].
Macroscopically, the transected mass had a fibrous appearance and
measured 6mm by 7mm (Fig. 3). On Hematoxylin-Eosin (HE)-stained
frozen sections, there were sporadic islet cell hypertrophy without the
clear presence of enlarged islets which made it difficult to confirm the
lesion was completely removed at frozen section; only the im-
munohistochemical stains done the following days showed the typical
changes of a focal lesion responsible for HI (Fig. 3). Therefore, we
carried out the dissection further first towards the pancreatic tail and
then towards the head to remove two additional specimens (Fig. 4),
which both showed normal macroscopic appearance as well as normal
microscopic structure on HE-stained frozen sections. Following removal
of the mass, the patient's blood glucose levels started to increase in-
traoperatively and reached a peak of 17.4mmol/L on a glucose infusion
rate of 5mg/kg/min, requiring insulin infusion. Despite the lack of
histologic confirmation of removal of the lesion, we considered it
substantively resected based on the macroscopic appearance, the pre-
liminary finding of the frozen sections, and on the hyperglycaemic re-
sponse. As the preserved pancreatic tail was more than 5 cm long, we
decided to preserve it and to assure drainage with a Roux-en-Y pan-
creatico-jejunostomy. To this end, we identified the proximal jejunum,
brought it outside the abdomen through a short extension of the um-
bilical incision [9]. We subsequently formed a foot-point anastomosis,
dividing the Jejunum 30 cm from the ligament of Treitz with sub-
sequent end-to-side (antimesenteric) anastomosis using a 5-0 absorb-
able monofilament suture in a running fashion (Fig. 4). In-
traabdominally again, we then brought the Roux jejunal limb through
the transverse mesocolon to the pancreatic tail, which was thoroughly
tucked into the open end of the Jejunum (Figs. 4 and 5); the pancrea-
tico-jejunal anastomosis was carried out using eight interrupted stitches
of 5-0 PDS® (Ethicon®, Cincinnati, OH; Fig. 5) and the hiatus created in
the transverse mesocolon was closed around the jejunal Roux limb. An
8-French silicone rubber drain was placed in the lesser sac before clo-
sure of all port sites. Duration of the procedure was 210min, which
included awaiting the results of frozen sections three times.
Postoperatively, the insulin infusion could be weaned off and
stopped after 6 h – he later reached a fasting tolerance of 12 h without
developing hypoglycaemia and undetectable insulin with generation of
fatty acids and ketones at the end of the fast suggestive of complete
resolution of HI. Diagnostic imaging performed to investigate recurrent
fever spikes and an elevated CRP (up to 165 μmol/L) revealed a mul-
tiloculated collection adjacent to the left lobe of the liver, which was
successfully treated with a 3 weeks course of intravenous antibiotics.
Besides the fever spikes, the patient recovered well from the procedure
and full oral feeds were reached after 9 days. Drain output, which
contained pancreatic secretions as confirmed by high amylase levels,
subsided 10 days after the procedure. Total inpatient care after the
operation was 4 weeks due to the course of intravenous antibiotic
treatment, which was extended to 3 weeks in the context of previous
long-standing immunosuppressive treatment. A recent ultrasound
showed complete resolution of the collection and no pancreatic duct
dilatations.
3. Discussion
Congenital HI is arguably the most common disease requiring
pancreatic resection in infants and toddlers, other indications such as
pancreatic neoplasms or chronic pancreatitis are exceedingly rare in
this age group. The type of disease determines the extent of pancreatic
resection; in focal disease, only as much tissue is resected as to safely
remove the pathologic mass.
Open operation is still the most common approach for near-total
pancreatectomy in cases of diffuse HI [10,11], although the technique
of laparoscopic near-total pancreatectomy has been developed and
described [5,12]. The open approach in general has several advantages,
it does not only allow for palpation of the pancreas for masses or no-
dules, it also permits easier access for intraoperative ultrasound than
laparoscopy. Intraoperative ultrasound is often essential to locate an
insulinoma and to avoid injury to the pancreatic duct [13–16]. On the
other hand, there are several reports of laparoscopic pancreatic resec-
tions, especially with focal lesions within the pancreatic tail
[5,12,17,18]. Surgeons may choose a laparoscopic approach for its re-
duced morbidity and pain and avoidance of the undesirable cosmetic
result of an upper transverse laparotomy; some also report much earlier
oral feeding and shorter hospitalization after laparoscopic resection
compared to open [18–20]. The use of intraoperative ultrasound is also
recommended for laparoscopic resections [15,19]. However, laparo-
scopic ultrasound may not be available in a paediatric hospital. Fur-
thermore, some reports raise the concern of an increased likelihood of
incomplete resection and the subsequent need for re-operation after
laparoscopic pancreatectomy [21]. Leakage of pancreatic fluid and
fistula formation is an additional concern with minimally invasive
pancreatectomy and pancreatico-jejunostomy [22]. In our case, output
from the drain placed in the lesser sac decreased over time and subsided
spontaneously on postoperative day 10. Overall, minimally invasive
pancreatectomy has important limitations; yet, successful laparoscopic
operations also offers distinct benefits to the patient.
In case of focal HI – such as in our patient – the mass can frequently
be enucleated resulting in a less than 5% loss of pancreatic tissue [16].
However, some patients with head or neck lesions of the pancreas still
require a proximal pancreatectomy and thus a pancreatico-jeju-
nostomy; additionally, enucleation can lead to injury of the pancreatic
duct [14,16]. In our case, at the point where we were confident that we
had removed the lesion, we had three options. First, to remove the
remaining tail, leaving less than 50% of pancreatic tissue having re-
moved already some of the head of the pancreas with the long-term risk
Fig. 1. A) Axial image of an 18F-DOPA PET contrast enhanced CT scan at the
level of the pancreas, showing a focal uptake in the area of the pancreatic neck.
(Abbreviations: 18F-DOPA=6-[18F]-L-fluoro-L-3, 4-dihydroxyphenylalanine.
PET= positron emission tomography).
B) Laparoscopic view after entering the lesser sac through the gastrocolic li-
gament and elevating the stomach using a Nathanson retractor. A slightly
prominent tissue mass is visible at the pancreatic neck.
C) Schematic drawing of laparoscopic findings. The major vessels which the
pancreas is overlying are shown.
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of diabetes. Second, to do an open pancreatico-jejunostomy to collect
and drain the secretions produced by the pancreatic tail. Third, to
perform the latter procedure laparoscopically, which we decided to do
to avoid a laparotomy with all its consequences. A drainage technique
for middle segmental pancreatic resections has been described after
resection of benign pancreatic body lesions operated in an open fashion
in adults [23,24]. An earlier case report of laparoscopic resection of a
pancreatic cystadenoma in a 55 year old woman described an end-to-
side anastomosis to assure drainage of the remaining distal pancreas
[25].
The fact that frozen sections of a macroscopically identified mass
had a normal appearance after HE-staining led to an intraoperative
decision-making dilemma. We considered cautery artefact as a potential
reason why sections of the mass did not display HI typical features;
however, no heat-induced changes were detected in the sections
through the mass. To reduce cautery artefacts, some recommend sharp
dissection for enucleation and transection of the distal pancreas in case
of a proximal pancreatectomy [10]. Also, focal lesions might feature
tentacles extending into otherwise healthy surrounding pancreatic
tissue. Therefore, confirmation of complete excision on frozen sections
is generally our standard [5]. However, since not even the macroscopic
mass displayed the HI-typical changes on frozen sections, we were
unable to assess eventual outgrowths from the mass until we had con-
firmation of complete removal using immunohistochemical staining.
Fig. 2. A) View of laparoscopic separation of the pancreas from the splenic vessels using hook cautery. A stay stitch adjacent to the tissue mass was placed to facilitate
elevation of the pancreas.
B) Schematic drawing of A).
C) Laparoscopic view after complete transection of the pancreas distal to the mass.
D) Schematic drawing of C).
Fig. 3. A) Transection of the pancreas
proximal to the mass using a
Harmonic® laparoscopic scalpel, which
seals the divided pancreatic duct.
B) Resected middle segment of the
pancreas containing the focal lesion.
C) Macroscopic image of the removed
and transected mass with the fibrous
white appearance adjacent to normal
pancreatic tissue.
D) Hematoxylin-Eosin stain from a
paraffin section through the mass,
showing islet cells with an enlarged cell
nucleus as sole abnormality.
E) Immunohistochemistry stain for pro-
insulin; the section is through the same
area as B) and shows an increase in
strongly positive endocrine tissue.
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We are currently investigating whether long-standing Sirolimus treat-
ment affects microscopic appearance of hyper productive pancreatic
islet cells.
To the best of our knowledge, we are herein reporting the first
paediatric case of a laparoscopically performed middle segmental
pancreatic resection with laparoscopic Roux-en-Y pancreatico-jeju-
nostomy. We suggest considering this approach for similar cases, since
it combines superior intraoperative visualisation with reduced surgical
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Fig. 4. A) Laparoscopic separation of
pancreatic body from the underlying
splenic vessels to resect a short segment
of pancreas distal to the already re-
sected neck.
B) Schematic illustration of the in-
traoperative situs.
C) View of the jejunal limb brought out
through the slightly extended umbilical
incision, prepared for the pancreatico-
jejunal anastomosis after forming the
foot-point anastomosis.
D) Laparoscopic view of the jejunal
limb juxtaposed to the pancreatic tail
after bringing the jejunum through the
transverse mesocolon and fashioning
the posterior part of the anastomosis.
E) Schematic representation of in-
traoperative situs after completion of
the dorsal part of the anastomosis.
Fig. 5. A) Picture of the laparoscopically completed pancreatico-jejunal anastomosis before drain placement.
B) Schematic drawing of the pancreatico-jejunal anastomosis.
C) Photograph of the immediate postoperative appearance of the patient's abdomen with the drain and the previously placed percutaneous endoscopic gastrostomy
(PEG) in situ.
D) Photograph of the patient's abdomen 3 months after the operation, showing the well healed short wounds of the trocar sites.
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